Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C - Wikidata - awgldk - TriplyDB

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

http://www.wikidata.org/entity/Q24201588

about

Direct-acting antivirals for chronic hepatitis C Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis Type I interferons for induction of remission in ulcerative colitis Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Aminoadamantanes for chronic hepatitis C Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Overview and recent trends of systematic reviews and meta-analyses in hepatology.Direct-acting antivirals for chronic hepatitis C.Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response.Health state utilities associated with attributes of treatments for hepatitis C.Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders Direct-acting antivirals for chronic hepatitis C

P2860

Q24185977-4ED94540-9CB9-482A-AF7F-88D5D28257BF Q24186846-E56ABC26-9153-4CA8-817A-5C28F5A052CF Q24187202-B33EE148-2BC0-491B-9035-A065D8B9FBB4 Q24193940-9A327462-B835-4E16-8803-2E18F2502D11 Q24194770-2533CD05-1783-428D-B0CF-91DDF8B363B7 Q24194815-4E446DE3-B2D5-4309-87B5-D698568194CB Q24200197-CB5F4059-2A1D-4DC5-BB59-96E0601FFBAD Q26830804-0A6B3B13-4F87-4134-B4E0-CA16D97D4142 Q30434752-F89A6099-A162-42CB-91FC-F52535935225 Q34557595-0330C33B-9748-4D7E-951D-4B9617F1B41A Q34700417-BDE86E92-ED78-4AFE-9454-9099E3CAA86D Q35933802-12A78503-7C17-43E9-8552-CA7B16B674F1 Q36285092-875C51F9-D76E-42CA-9677-188F09593058 Q37641036-14F2CA29-145F-4A2F-A5D7-5125E3930CF9 Q57389418-96F54D74-124B-4212-971F-1E34C6090B92

P2860

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

http://www.wikidata.org/entity/Q24201588

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@ast

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en-gb

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@nl

type

label

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@ast

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en-gb

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@nl

prefLabel

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@ast

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en-gb

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@nl

P1433

Q24201588-1A6CBD2E-5F64-45C0-BE0F-DBE02CD018D2

P1476

Q24201588-0DD5956C-23E4-437A-AD0F-319F9981166E

P2093

Q24201588-025961FA-8098-4881-AEE4-126B00D1330F

Q24201588-2D79B279-8D09-46C2-A096-A92D0F441210

Q24201588-3964606C-159C-4875-A753-AD3B172750A6

Q24201588-51CC32BF-A502-46D6-90CC-25A0A00337C0

Q24201588-61325BA3-B9FA-4AC5-9ABB-0E741435232B

Q24201588-A3585618-F41A-42B8-946C-490A39F5E641

Q24201588-C0BD55E4-E47D-4FBF-A5CD-F6AE1316C031

Q24201588-F91CC686-ED3D-43AB-94FD-B750D14B0B1D

P2860

Q24201588-00C48DD4-670F-4578-AC84-F21D38406FE8

Q24201588-01289265-6409-41A7-9DEC-A78DB5D752A5

Q24201588-066F099C-8EEA-4126-A2F9-52B117CAA0DE

Q24201588-06A1A104-273E-4AD1-BFEA-9729458316C3

Q24201588-0929B35E-6C11-4735-A1A5-7C4787022071

Q24201588-0A0F8DFF-9499-4355-A96E-30C955E86AB7

Q24201588-0AA25B76-C6AC-4A2F-BEFA-5B2F450C52B2

Q24201588-0ACB3D62-2EFF-4920-B4DA-EB8529023037

Q24201588-0E4689AD-BB41-4C80-B600-2A38DE75F3DD

Q24201588-11A505AD-CE99-4D8B-BE05-B9C1AC164487

P304

Q24201588-46F2607D-DE52-4575-AB51-5F14255128D4

P31

Q24201588-1FDD5B9E-A905-4FC9-8CFE-DAB258A8F1A3

Q24201588-cecb66df-50f2-49af-8cf4-e5fd1eac4a89

P356

Q24201588-24CDBCA0-9D42-4AE9-AF1C-ADD4479DA2C9

P433

Q24201588-4460F644-2D9F-42F7-B593-88E9D8BF23BD

P50

Q24201588-30D0DACD-5982-4A7E-8831-04F94BC0B300

Q24201588-7089CE94-0589-4AEC-8E11-1CC3204D3141

Q24201588-BFFA3691-D47F-4621-845B-5E7ED5300020

P577

Q24201588-C0C42D67-3D5B-4E9C-A5B4-C8AD9B77DAEB

P698

Q24201588-D1EF7DEE-95AE-4265-94F1-C4437B9BD449

P932

Q24201588-9EE9B284-1BFA-4C05-986A-F29045ED67FA

P356

14651858.CD003617.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

@en

P2093

Andrew K Burroughs

http://www.w3.org/2001/XMLSchema#string

Brian R Davidson

http://www.w3.org/2001/XMLSchema#string

Kurinchi Selvan Gurusamy

http://www.w3.org/2001/XMLSchema#string

Maria Pleguezuelo

http://www.w3.org/2001/XMLSchema#string

Pilar Barrera Baena

http://www.w3.org/2001/XMLSchema#string

Ronald L Koretz

http://www.w3.org/2001/XMLSchema#string

Ruben Ciria

http://www.w3.org/2001/XMLSchema#string

Vasiliki Arvaniti

http://www.w3.org/2001/XMLSchema#string

P2860

Ribavirin plus interferon versus interferon for chronic hepatitis C

Ribavirin monotherapy for chronic hepatitis C

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Bias in meta-analysis detected by a simple, graphical test

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Quantifying heterogeneity in a meta-analysis

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Meta-analysis in clinical trials

P304

CD003617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD003617.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P50

Kurinchi Selvan Gurusamy

Brian R Davidson

Andrew K Burroughs

P577

2013-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23440791

http://www.w3.org/2001/XMLSchema#string

P932

6599819

http://www.w3.org/2001/XMLSchema#string